COMMITMENTS AND CONTINGENCIES (Details) |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
|
Apr. 30, 2026
USD ($)
|
Aug. 31, 2021
USD ($)
|
Aug. 31, 2021
EUR (€)
|
Jun. 30, 2021
USD ($)
|
Dec. 31, 2025
Milestone
|
|
| Cleave Therapeutics, Inc | |||||
| COMMITMENTS AND CONTINGENCIES | |||||
| Number of milestones achieved | 0 | ||||
| BioInvent International AB | |||||
| COMMITMENTS AND CONTINGENCIES | |||||
| Number of milestones achieved | 0 | ||||
| Black Belt Therapeutics Ltd | |||||
| COMMITMENTS AND CONTINGENCIES | |||||
| Number of milestones achieved | 0 | ||||
| Milestone payment | $ 305,000 | € 250,000 | $ 750,000 | ||
| Pharmathen Global BV | |||||
| COMMITMENTS AND CONTINGENCIES | |||||
| Number of milestone payments yet to be paid | 1 | ||||
| Acrotech Biopharma LLC | Subsequent event | |||||
| COMMITMENTS AND CONTINGENCIES | |||||
| Milestone payment | $ | $ 250,000 | ||||
| Total consideration paid over term of agreement | $ | $ 1,250,000 | ||||